Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 test

Ellume facilities in Brisbane will feature BAMS technology to automate COVID-19 test lines. Image credit: Ellume

Bosch Australia’s Manufacturing Solutions Division (BAMS), a supplier of factory automation for the medical device industry, has announced that digital diagnostics company, Ellume, will introduce BAMS technology to automate the high volume production of its COVID-19 diagnostic tests.

Brisbane-based Ellume has developed a suite of COVID-19 tests for use by laboratories, doctors and consumers that gives results in less than 15 minutes. The Ellume technology was developed to address the unprecedented global demand for rapid, accurate diagnostics.

The first batch of product has already been shipped to the United States and Ellume’s new manufacturing facility in Richlands, Brisbane, is rapidly scaling-up its production capacity.

President of Bosch Australia, Gavin Smith, said the company was delighted to bring BAMS automation expertise to support Australian med-tech manufacturing.

Ellume CEO and founder Dr Sean Parsons said the role of rapid and accurate diagnostics has never been more important.

“Ellume is pleased to be working with Bosch to bring their world-leading automation know-how to our manufacturing process. This will allow Ellume to manufacture best-in-class diagnostics that can be relied on in a health crisis,” he said.

With deep experience in factory automation solutions, and a growing portfolio of med-tech clients, BAMS has the ability to create robust and resilient manufacturing processes for Ellume.